Omega-3 intake counteracts symptoms of anxiety and depression in mice
New animal research suggesting omega‑3 fatty acids can reduce stress‑induced anxiety and depression in mice prompts comparisons with existing human studies, where fish oil and EPA/DHA supplements show modest benefits, especially as adjuncts to antidepressants. Commenters highlight major uncertainties around dosage, supplement quality, and the importance of the overall omega‑3 to omega‑6 ratio, with some emphasizing better evidence for getting these fats from fish rather than pills. Others share mixed personal experiences—ranging from mood stabilization to side effects like arrhythmias or “flatlined” emotions—and note broader issues such as the limits of mouse models, individual genetic differences, and potential risks of rancid or polluted oils.
Existing human evidence & effectiveness
- Commenters note that omega-3’s effects on depression/anxiety have already been studied in humans.
- Summaries referenced: fish oil shows moderate improvement for major depression, small for anxiety; more benefit as an adjunct to antidepressants than alone.
- Some stress that a “moderate” effect size is actually quite meaningful among supplements.
Mechanisms, EPA vs DHA, omega-3 vs omega-6
- Several posts argue “omega-3” is too vague; EPA and DHA have distinct roles, with EPA often linked to antidepressant effects.
- Some discuss endocannabinoids: omega‑6–derived ones being more THC‑like (glutamate‑increasing, potentially anxiety/psychosis‑promoting) and omega‑3–derived more CBD‑like (GABA‑increasing, potentially anxiolytic).
- Others emphasize overall omega‑3:omega‑6 ratio, with too much omega‑6 (e.g., vegetable oils) alleged to worsen anxiety or inflammation.
Supplements vs dietary sources & quality concerns
- Repeated concern that many omega‑3 supplements are low quality, rancid, or underdosed; “wild west” market.
- Some argue fish/seafood and possibly algae are preferable to pills due to co‑factors and better evidence.
- Cod liver oil is popular but raises concerns about pollutants, processing, and excess vitamin A/D.
- A few brands are mentioned as “well‑tested,” but no consensus.
Dosing, safety, and side effects
- High-dose omega‑3 (grams per day) is said in some comments to potentially cause arrhythmias or increase AFib/stroke risk; at least one person reports dose‑dependent palpitations.
- Interactions with antidepressants are mentioned, including “brain zaps” when combined with duloxetine.
- Unclear where the risk threshold lies; doses and individual susceptibility vary.
Anecdotal experiences
- Multiple anecdotes: improved mood, reduced “monkey mind,” better schizoaffective or anxiety symptoms when increasing omega‑3 and/or lowering omega‑6.
- Others report no benefit, or mixed/negative experiences.
- Some report marked benefit from high‑EPA products specifically.
Skepticism, study design, and limits
- Several note that many supplement benefits fade in larger trials, and that mouse results often don’t translate to humans.
- Others argue waiting for perfect long‑term RCTs is impractical; a “kitchen‑sink” adjunctive approach is reasonable if risks are low.
- One thread questions why mice are still used, with the reply that invasive mechanistic work (e.g., brain tissue analysis) isn’t feasible in humans.
Related threads
- Extended side discussion on dry eye: many report little to no benefit from omega‑3; other treatments and lifestyle changes dominate that discussion.
- Ethical concerns about massive use and suffering of lab mice are raised.
- Broader point: effects of diet/supplements are highly individual and can be strongly shaped by genetics and specific metabolic pathways.